Daniel Loeb Third Point
Daniel Loeb is the founder of Third Point, an event-driven and activist-oriented hedge fund. He is known for pointed letters to management teams, catalyst-driven investing, and a flexible mandate across equities and credit. Loeb’s campaigns and portfolio shifts regularly generate attention beyond specialist hedge fund circles.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$400M |
| 2 |
Bank of America
BAC
|
+$337M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$267M |
| 4 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$229M |
| 5 |
Humana
HUM
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$872M |
| 2 |
Alibaba
BABA
|
+$275M |
| 3 |
MON
Monsanto Co
MON
|
+$267M |
| 4 |
Meta Platforms (Facebook)
META
|
+$239M |
| 5 |
TransDigm Group
TDG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.7% |
| 2 | Communication Services | 14.76% |
| 3 | Financials | 14.38% |
| 4 | Materials | 13.32% |
| 5 | Industrials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Conagra Brands
CAG
$7.89B
| $119M | 1.16% |
3,000,000
-2,461,250
| -45% | -$92M |
|
|
MON
27
DELISTED
Monsanto Co
MON
| $116M | 1.14% |
1,100,000
-2,600,000
| -70% | -$267M |
|
28
Nomad Foods
NOMD
$1.65B
| $114M | 1.12% |
11,950,000
-700,000
| -6% | -$7.64M |
|
29
Goldman Sachs
GS
$303B
| $95.8M | 0.94% |
+400,000
| New | +$81.2M |
|
|
HDS
30
DELISTED
HD Supply Holdings, Inc.
HDS
| $95.6M | 0.94% |
+2,250,000
| New | +$83M |
|
31
Green Brick Partners
GRBK
$3.09B
| $81.2M | 0.8% |
8,083,022
| – | – |
|
|
32
TransDigm Group
TDG
$66.4B
| $62.2M | 0.61% |
250,000
-881,000
| -78% | -$231M |
|
|
RICE
33
DELISTED
Rice Energy Inc.
RICE
| $56.6M | 0.56% |
+2,650,000
| New | +$63.2M |
|
|
SWN
34
DELISTED
Southwestern Energy Company
SWN
| $54.1M | 0.53% |
+5,000,000
| New | +$57.2M |
|
35
Broadcom
AVGO
$1.75T
| $53M | 0.52% |
+3,000,000
| New | +$52M |
|
|
KDMN
36
DELISTED
Kadmon Holdings, Inc.
KDMN
| $42.1M | 0.41% |
7,919,650
| – | – |
|
|
SUPV
37
Grupo Supervielle
SUPV
$692M
| $36M | 0.35% |
2,740,000
-1,760,000
| -39% | -$25.2M |
|
38
Enphase Energy
ENPH
$5.1B
| $6.31M | 0.06% |
6,248,987
| – | – |
|
39
Ametek
AME
$54.9B
| – | – |
-1,250,000
| Closed | -$59.7M |
|
|
40
Alibaba
BABA
$286B
| – | – |
-2,600,000
| Closed | -$275M |
|
41
AB InBev
BUD
$155B
| – | – |
-1,600,000
| Closed | -$210M |
|
42
Liberty Global Class A
LBTYA
$3.63B
| – | – |
-3,000,000
| Closed | -$103M |
|
43
Visa
V
$693B
| – | – |
-2,100,000
| Closed | -$174M |
|
44
Williams Companies
WMB
$86.2B
| – | – |
-4,000,000
| Closed | -$123M |
|
45
Yum! Brands
YUM
$41.8B
| – | – |
-695,500
| Closed | -$45.4M |
|
|
AGN
46
DELISTED
Allergan plc
AGN
| – | – |
-3,785,000
| Closed | -$872M |
|
|
C.WS.A
47
DELISTED
Citigroup Inc
C.WS.A
| – | – |
-20,000,000
| Closed | -$1.04M |
|
|
STJ
48
DELISTED
St Jude Medical
STJ
| – | – |
-2,600,000
| Closed | -$207M |
|
|
APIC
49
DELISTED
Apigee Corporation Common Stock
APIC
| – | – |
-3,166,551
| Closed | -$55.1M |
|
|
SHPG
50
DELISTED
Shire pic
SHPG
| – | – |
-900,000
| Closed | -$174M |
|
Similar funds
Daniel Loeb's Q4 2016 Portfolio in Review
As of Q4 2016, Daniel Loeb held 50 positions worth $10.2B, down 11% from $11.5B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Daniel Loeb withdrew a net $1.35B in Q4 2016, closing 12 positions and reducing 15 holdings. Its most notable exit was Allergan plc, an estimated $872M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Daniel Loeb opened a new position in JPMorgan Chase worth $453M.
- Daniel Loeb's largest Q4 2016 buy was JPMorgan Chase: 5,250,000 shares worth $453M.
- Daniel Loeb added most to Humana in Q4 2016, an estimated $191M increase.
- Daniel Loeb's biggest Q4 2016 reduction was Monsanto Co, cutting an estimated $267M.
- Daniel Loeb fully exited Allergan plc in Q4 2016, selling an estimated $872M.
- Daniel Loeb's ten largest holdings make up 62% of its $10.2B portfolio in Q4 2016.
- Daniel Loeb opened 12 new positions and closed 12 in Q4 2016.
- Daniel Loeb's portfolio value fell 11% quarter-over-quarter to $10.2B.
Based on Third Point's 13F filing for Q4 2016, filed 10 Feb 2017.